Onderzoeker
Nora Sundahl
- Disciplines:Palliatieve zorg en zorg rond het levenseinde, Laboratoriumgeneeskunde, Andere translationele wetenschappen, Morfologische wetenschappen, Regeneratieve geneeskunde, Oncologie, Verpleegkunde, Andere klinische wetenschappen, Andere basiswetenschappen, Andere paramedische wetenschappen, Andere gezondheidswetenschappen, Andere medische en gezondheidswetenschappen
Affiliaties
- Vakgroep Structuur en Herstel van de Mens (Departement)
Lid
Vanaf1 okt 2018 → 22 sep 2019 - Vakgroep Radiotherapie en Experimenteel Kankeronderzoek (Departement)
Lid
Vanaf1 aug 2016 → 30 sep 2018
Publicaties
1 - 10 van 31
- Microbiome and metabolome dynamics during radiotherapy for prostate cancer(2023)
Auteurs: Willeke Danckaert, Mathieu Spaas, Nora Sundahl, Aurélie De Bruycker, Valerie Fonteyne, Ellen De Paepe, Carlos De Wagter, Lynn Vanhaecke, Piet Ost
- Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors : the CHEERS phase 2 randomized clinical trial(2023)
Auteurs: Mathieu Spaas, Nora Sundahl, Vibeke Kruse, Sylvie Rottey, Daan De Maeseneer, Fréderic Duprez, Yolande Lievens, Veerle Surmont, Lieve Brochez, Dries Reynders, et al.
Pagina's: 1205 - 1213 - Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial(2021)Volume: 161
Auteurs: Mathieu Spaas, Nora Sundahl, VIBEKE KRUSE, Daan De Maeseneer, Piet Dirix, Robin Van den Begin, Dirk Van Gestel, Vincent Renard, D Reynders, Els Goetghebeur, et al.
Pagina's: S490 - S491 - Immune monitoring in melanoma and urothelial cancer patients treated with anti-PD-1 immunotherapy and SBRT discloses tumor specific immune signatures(2021)
Auteurs: Annabel Meireson, Simon Tavernier, Sofie Van Gassen, Nora Sundahl, Annelies Demeyer, Mathieu Spaas, Vibeke Kruse, Liesbeth Ferdinande, Jo Van Dorpe, Benjamin Hennart, et al.
- Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial(2021)
Auteurs: Mathieu Spaas, Nora Sundahl, Eva Hulstaert, Vibeke Kruse, Daan De Maeseneer, Annabel Meireson, Lieve Brochez, Dries Reynders, Els Goetghebeur, Robbe Van den Begin, et al.
- Phase 2 trial of nivolumab combined with stereotactic body radiation therapy in patients with metastatic or locally advanced inoperable melanoma(2019)
Auteurs: Nora Sundahl, Teofila Seremet, Bart Neyns, Liesbeth Ferdinande, Annabel Meireson, Lieve Brochez, Vibeke Kruse, Piet Ost
Pagina's: 828 - 835 - Very late xerostomia, dysphagia, and neck fibrosis after head and neck radiotherapy(2019)
Auteurs: Margot Baudelet, Leen Van den Steen, Peter Tomassen, Katrien Bonte, Philippe Deron, Wouter Huvenne, Sylvie Rottey, Wilfried De Neve, Nora Sundahl, Gwen Van Nuffelen, et al.
Pagina's: 3594 - 3603 - Boosting anticancer immunity with radiotherapy(2019)
Auteurs: Nora Sundahl
- Phase 1 dose escalation trial of ipilimumab and stereotactic body radiation therapy in metastatic melanoma(2018)
Auteurs: Nora Sundahl, Katrien De Wolf, Vibeke Kruse, Annabel Meireson, Dries Reynders, Els Goetghebeur, Mireille Van Gele, Reinhart Speeckaert, Benjamin Hennart, Lieve Brochez, et al.
Pagina's: 906 - 915 - Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma(2018)
Auteurs: Lieve Brochez, Annabel Meireson, Ines Chevolet, Nora Sundahl, Piet Ost, Vibeke Kruse